CLINICAL_TRIALS
trial_result
· 2022-02-18
Clinical Trial Update: Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007) [Phase 2]
Summary
Phase 2 trial update for etoricoxib (MK-0663-007) in osteoarthritis has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED